Value of investments made in ToolGen South Korea 2000-2018

Published by Statista Research Department, Jun 26, 2024
In 2018, ToolGen attracted around 30 billion South Korean won of investments by KTB Network, Intervest, IMM Investment, Smilegate Investment, and KB Securities. That year, the value of investments made in ToolGen was around 30 billion South Korean won. ToolGen is a South Korean biotech company based on CRISPR genome editing technology.

Value of investments made in ToolGen in South Korea from 2000 to 2018 (in billion South Korean won)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2018

Region

Worldwide

Survey time period

2000 to 2018

Supplementary notes

Note: 1,000 South Korean won equal 0.84 U.S. dollars and 0.70 euros as of September 2020.
Figures have been rounded.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Medical biotech industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Medical biotech industry

Global overview

7

U.S. and European landscape

6

Focus: U.S. companies

8

Research & development

6

Products

5

Funding/M&A/IPOs

6

Focus: RNA/mRNA

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

CRISPR genome editingGlobal pharmaceutical industryBiotech drugsGenetically modified cropsAgriculture in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.